These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29065450)

  • 61. Ubiquitin and ubiquitin-like specific proteases targeted by infectious pathogens: Emerging patterns and molecular principles.
    Edelmann MJ; Kessler BM
    Biochim Biophys Acta; 2008 Dec; 1782(12):809-16. PubMed ID: 18817868
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Targeted protein degradation as a tumor suppressor.
    Arat NO; Harrington L
    Cell Cycle; 2014; 13(22):3473. PubMed ID: 25493413
    [No Abstract]   [Full Text] [Related]  

  • 63. Herpesvirus ubiquitin deconjugases.
    Masucci MG
    Semin Cell Dev Biol; 2022 Dec; 132():185-192. PubMed ID: 34776333
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Defective ribosomal products challenge nuclear function by impairing nuclear condensate dynamics and immobilizing ubiquitin.
    Mediani L; Guillén-Boixet J; Vinet J; Franzmann TM; Bigi I; Mateju D; Carrà AD; Morelli FF; Tiago T; Poser I; Alberti S; Carra S
    EMBO J; 2019 Aug; 38(15):e101341. PubMed ID: 31271238
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Specificity in Ubiquitination Triggered by Virus Infection.
    Gu H; Jan Fada B
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32521668
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Targeting the ubiquitin system for treatment of cilia-related diseases].
    Nishimura Y; Inagaki M
    Nihon Yakurigaku Zasshi; 2021; 156(1):4-8. PubMed ID: 33390480
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Central Role of the Ubiquitin-Proteasome System in EBV-Mediated Oncogenesis.
    Pei Y; Robertson ES
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158879
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ubiquitin-proteasome system: Rescuing EBV latency.
    Bucci M
    Nat Chem Biol; 2017 Aug; 13(9):923. PubMed ID: 28820873
    [No Abstract]   [Full Text] [Related]  

  • 69. Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors.
    Hui KF; Tam KP; Chiang AKS
    Viruses; 2017 Nov; 9(11):. PubMed ID: 29160853
    [TBL] [Abstract][Full Text] [Related]  

  • 70. KSHV inhibits stress granule formation by viral ORF57 blocking PKR activation.
    Sharma NR; Majerciak V; Kruhlak MJ; Zheng ZM
    PLoS Pathog; 2017 Oct; 13(10):e1006677. PubMed ID: 29084250
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evidence for Kaposi Sarcoma Originating from Mesenchymal Stem Cell through KSHV-induced Mesenchymal-to-Endothelial Transition.
    Li Y; Zhong C; Liu D; Yu W; Chen W; Wang Y; Shi S; Yuan Y
    Cancer Res; 2018 Jan; 78(1):230-245. PubMed ID: 29066510
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
    Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
    Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
    [TBL] [Abstract][Full Text] [Related]  

  • 73. EBV latent membrane protein 2A orchestrates p27
    Fish K; Sora RP; Schaller SJ; Longnecker R; Ikeda M
    Blood; 2017 Dec; 130(23):2516-2526. PubMed ID: 29074502
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel Role of vBcl2 in the Virion Assembly of Kaposi's Sarcoma-Associated Herpesvirus.
    Liang Q; Wei D; Chung B; Brulois KF; Guo C; Dong S; Gao SJ; Feng P; Liang C; Jung JU
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167347
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Epstein-Barr Virus Episome Maneuvers between Nuclear Chromatin Compartments during Reactivation.
    Moquin SA; Thomas S; Whalen S; Warburton A; Fernandez SG; McBride AA; Pollard KS; Miranda JL
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29142137
    [TBL] [Abstract][Full Text] [Related]  

  • 76. EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
    Fitzsimmons L; Kelly GL
    Viruses; 2017 Nov; 9(11):. PubMed ID: 29137176
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Latent Membrane Protein 1 Is a Novel Determinant of Epstein-Barr Virus Genome Persistence and Reactivation.
    Caves EA; Butch RM; Cook SA; Wasil LR; Chen C; Di YP; Lee N; Shair KHY
    mSphere; 2017; 2(6):. PubMed ID: 29134204
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characterization of the EBV-Induced Persistent DNA Damage Response.
    Hafez AY; Luftig MA
    Viruses; 2017 Dec; 9(12):. PubMed ID: 29194355
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Early Nuclear Events after Herpesviral Infection.
    Full F; Ensser A
    J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31500286
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Promyelocytic leukemia (PML) nuclear bodies (NBs) induce latent/quiescent HSV-1 genomes chromatinization through a PML NB/Histone H3.3/H3.3 Chaperone Axis.
    Cohen C; Corpet A; Roubille S; Maroui MA; Poccardi N; Rousseau A; Kleijwegt C; Binda O; Texier P; Sawtell N; Labetoulle M; Lomonte P
    PLoS Pathog; 2018 Sep; 14(9):e1007313. PubMed ID: 30235352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.